CTX-1211
CTX-1211 is a selective, orally effective melanocortin MC4R agonist (EC50=0.38 nM) . CTX-1211 can enhance the feeding suppression and weight loss effects induced by liraglutide (HY-P0014), and promote anorexia and weight loss activity. CTX-1211 is mainly used in the study of obesity and other metabolic disorders[1].
Product Specifications
UNSPSC
12352209
Target
Melanocortin Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Metabolic Disease
Smiles
O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CSSC[C@@H](C(N)=O)NC1=O)C(N[C@@H](CC(O)=O)C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(O)=O)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CCCNC(N)=N)C(N[C@H]1CC3=CNC4=CC=CC=C34)=O)=O)=O)=O)=O)=O)=O)=O)C
Molecular Formula
C57H83N21O15S2
Molecular Weight
1366.53
References & Citations
[1]Dahir NS, et al. Inhibition of the melanocortin-3 receptor (MC3R) causes generalized sensitization to anorectic agents. bioRxiv [Preprint]. 2023 Dec 7:2023.12.05.570114.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
MC4R
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
